Net Cash Provided by (Used in) Operating Activities |
631M |
USD |
+54.1% |
Q4 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-3.96B |
USD |
-388% |
Q4 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
3.42B |
USD |
+697% |
Q4 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
2.5K |
shares |
0% |
Q4 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
91.9M |
USD |
+207% |
Q4 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.88B |
USD |
+14.4% |
Q4 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
4.6M |
USD |
-54.9% |
Q3 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
474M |
USD |
-16.7% |
Q4 2024 |
Q1 2025 |
Deferred Income Tax Expense (Benefit) |
226M |
USD |
|
Q4 2024 |
Q1 2025 |
Preferred Stock, Shares Authorized |
10K |
shares |
0% |
Q3 2024 |
FY 2024 |
Unrecognized Tax Benefits |
59.8M |
USD |
+34.7% |
Q3 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
184M |
USD |
+6.42% |
Q4 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
194M |
USD |
+31% |
Q3 2024 |
FY 2024 |
Interest Expense |
2.56B |
USD |
+31.6% |
Q4 2024 |
Q1 2025 |
Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2024 |
FY 2024 |